PRO32 DE NOVO ECONOMIC MODEL TO ASSESS THE IMPACT OF SIZE AND DURABILITY OF EFFECT OF CURATIVE CELL AND GENE THERAPIES IN TREATMENT OF PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2362
https://www.valueinhealthjournal.com/article/S1098-3015(19)34740-0/fulltext
Title :
PRO32 DE NOVO ECONOMIC MODEL TO ASSESS THE IMPACT OF SIZE AND DURABILITY OF EFFECT OF CURATIVE CELL AND GENE THERAPIES IN TREATMENT OF PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34740-0&doi=10.1016/j.jval.2019.09.2362
First page :
Section Title :
Open access? :
No
Section Order :
12059